Physician profile
Jerry Hsu
NPI 1306391552
$2,033.10
in general payments reported to CMS, 2019-2025
8 companies · $915 in 2025
The $915 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,118 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,967 · Travel and Lodging: $65.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,967.18 |
| Travel and Lodging | $65.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $671.88 | 2024-2025 | Clareon, Tryptyr, Lensx |
| Biotissue Holdings INC. | $559.62 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $287.46 | 2024-2025 | Stellaris |
| Johnson & Johnson Surgical Vision, INC. | $155.21 | 2025 | Tecnis Iol |
| Rayner Intraocular Lenses Limited | $124.24 | 2024 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Carl Zeiss Meditec Cataract Technology INC. | $110.42 | 2024 | |
| Glaukos Corporation | $101.48 | 2024 | Ce-Marked Kxla System |
| Harrow Eye, LLC | $22.79 | 2025 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.